Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Therapy”

1,256 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,256 results

Not applicableLooking for participantsNCT04638751
What this trial is testing

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Who this might be right for
Non-small Cell Lung CancerColorectal CancerTriple Negative Breast Cancer+1 more
Persephone Biosciences 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT07264842
What this trial is testing

Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars.

Who this might be right for
Pulpal Necrosis
Dow University of Health Sciences 60
Not applicableLooking for participantsNCT07374354
What this trial is testing

Preemptive Analgesia for Pain and Anxiety Control in Children With MIH

Who this might be right for
Pain and Anxiety in Children With MIH
October University for Modern Sciences and Arts 46
Not applicableStudy completedNCT04050254
What this trial is testing

TDCS Combined With Therapeutic Exercise in Fibromyalgia Patients

Who this might be right for
Fibromyalgia
University of Castilla-La Mancha 120
Testing effectiveness (Phase 2)Looking for participantsNCT06401005
What this trial is testing

SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Hubei Cancer Hospital 51
Large-scale testing (Phase 3)Looking for participantsNCT05633654
What this trial is testing

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Who this might be right for
Triple Negative Breast Cancer
Gilead Sciences 1,514
Large-scale testing (Phase 3)Study completedNCT03317223
What this trial is testing

Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients

Who this might be right for
Helicobacter Pylori Infection
HK inno.N Corporation 350
Not applicableStudy completedNCT07150286
What this trial is testing

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

Who this might be right for
Immune Thrombocytopenic PurpuraHELICOBACTER PYLORI INFECTIONS
Al-Mustansiriyah University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06992336
What this trial is testing

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Not applicableUnknownNCT04582955
What this trial is testing

Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy

Who this might be right for
Triple-negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Not applicableUnknownNCT04901728
What this trial is testing

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)

Who this might be right for
HIV Infections
University of Sussex 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Post-approval studies (Phase 4)UnknownNCT03134378
What this trial is testing

10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication

Who this might be right for
Helicobacter Pylori Infection
Indonesia University 73
Post-approval studies (Phase 4)Looking for participantsNCT06311942
What this trial is testing

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

Who this might be right for
HCC
Chen Xiaoping 300
Post-approval studies (Phase 4)Study completedNCT06905483
What this trial is testing

Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study

Who this might be right for
COPDChronic Obstructive Pulmonary Disease (COPD)Small Airway Disease+2 more
Thammasat University 22
Large-scale testing (Phase 3)Looking for participantsNCT06103864
What this trial is testing

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 625
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Very early researchStudy completedNCT00640861
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 45
Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Testing effectiveness (Phase 2)Study completedNCT03004183
What this trial is testing

SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC

Who this might be right for
Metastatic Non-small Cell Lung CancerMetastatic Triple-negative Breast Cancer
The Methodist Hospital Research Institute 57
Load More Results